Inventor
TRAVINS JEREMY
US26 patents
⚠️ This page may combine multiple inventors who share the name “TRAVINS JEREMY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AGIOS PHARMACEUTICALS INC
19 patentsUS9474779B2Oct 25, 2016
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC36 citations97
US9512107B2Dec 6, 2016
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC25 citations94
US9850277B2Dec 26, 2017
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC22 citations93
US9732062B2Aug 15, 2017
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC18 citations92
US9656999B2May 23, 2017
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC16 citations92
US10294215B2May 21, 2019
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC6 citations84
US9724350B2Aug 8, 2017
N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
AGIOS PHARMACEUTICALS INC12 citations80
US11505538B1Nov 22, 2022
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC1 citations73
US10717764B2Jul 21, 2020
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC1 citations72
US10640534B2May 5, 2020
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC2 citations72
US10111878B2Oct 30, 2018
N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
AGIOS PHARMACEUTICALS INC2 citations69
US11021515B2Jun 1, 2021
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC0 citations62
US10946023B2Mar 16, 2021
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC0 citations62
US10202339B2Feb 12, 2019
Therapeutic compounds and compositions
AGIOS PHARMACEUTICALS INC1 citations62
US10011574B2Jul 3, 2018
Glutaminase inhibitors and method of use
AGIOS PHARMACEUTICALS INC1 citations62
US10689375B2Jun 23, 2020
Compounds and their methods of use
AGIOS PHARMACEUTICALS INC0 citations52
US10414740B2Sep 17, 2019
Glutaminase inhibitors and method of use
AGIOS PHARMACEUTICALS INC0 citations52
US10087172B2Oct 2, 2018
Compounds and their methods of use
AGIOS PHARMACEUTICALS INC0 citations52
US10689414B2Jun 23, 2020
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC0 citations51